About this trial
This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be collected to correlate phenotype with absolute neutrophil count (ANC).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025
Parental informed consent obtained
Umbilical cord blood available for routine testing
Disqualifiers
None
Trial population
Neonates born at Kaplan Medical Center
Trial design
Cohort
Prospective
Treatments tested in this trial
Cord blood
Diagnostic testCord blood samples will be collected during routine G6PD testing. An additional 3 mL will be obtained non-invasively from the umbilical cord to determine the expression of Duffy antigens using serologic gel testing.
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of Duffy null phenotype in neonates
Percentage of neonates born with the Duffy null phenotype (Fya-/Fyb-) as determined by serologic gel-based testing.
Secondary outcomes
Prevalence of neutropenia in infants with Duffy null phenotype
Percentage of Duffy null infants with ANC \<1000/µL based on routine CBC performed at at 9-12 months
Association between parental ethnicity and Duffy null phenotype
Distribution of Duffy null phenotype stratified by self-reported parental origin.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.